Rachel J Keith1, Jessica L Fetterman2, Olusola A Orimoloye3, Zeina Dardari3, Pawel K Lorkiewicz1, Naomi M Hamburg2, Andrew P DeFilippis1, Michael J Blaha3, Aruni Bhatnagar1. 1. American Heart Association Tobacco, Regulation and Addiction Center, University of Louisville School of Medicine, Louisville, KY. 2. American Heart Association Tobacco, Regulation and Addiction Center, Vascular Biology Section, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA. 3. American Heart Association Tobacco, Regulation and Addiction Center, Ciccarone Center for the Prevention of Heart Disease, John Hopkins Hospital, Baltimore, MD.
Abstract
INTRODUCTION: Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. METHODS: A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21-45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. RESULTS: Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6-910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. CONCLUSION: Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. IMPLICATIONS: ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.
INTRODUCTION: Limited research exists about the possible cardiovascular effects of electronic nicotine delivery systems (ENDS). We therefore sought to compare exposure to known or potentially cardiotoxic volatile organic compounds (VOCs) in ENDS users, smokers, and dual users. METHODS: A total of 371 individuals from the Cardiovascular Injury due to Tobacco Use study, a cross-sectional study of healthy participants aged 21-45 years, were categorized as nonusers of tobacco (n = 87), sole ENDS users (n = 17), cigarette smokers (n = 237), and dual users (n = 30) based on 30-day self-reported tobacco product use patterns. Participants provided urine samples for VOC and nicotine metabolite measurement. We assessed associations between tobacco product use and VOC metabolite measures using multivariable-adjusted linear regression models. RESULTS: Mean (SD) age of the population was 32 (±6.8) years, 55% men. Mean urinary cotinine level in nonusers of tobacco was 2.6 ng/mg creatinine, whereas cotinine levels were similar across all tobacco product use categories (851.6-910.9 ng/mg creatinine). In multivariable-adjusted models, sole ENDS users had higher levels of metabolites of acrolein, acrylamide, acrylonitrile, and xylene compared with nonusers of tobacco, but lower levels of most VOC metabolites compared with cigarette smokers or dual users. In direct comparison of cigarettes smokers and dual users, we found lower levels of metabolites of styrene and xylene in dual users. CONCLUSION: Although sole ENDS use may be associated with lower VOC exposure compared to cigarette smoking, further study is required to determine the potential health effects of the higher levels of certain reactive aldehydes, including acrolein, in ENDS users compared with nonusers of tobacco. IMPLICATIONS: ENDS use in conjunction with other tobacco products may not significantly reduce exposure to VOC, but sole use does generally reduce some VOC exposure and warrants more in-depth studies.
Authors: Jean-François Etter; Chris Bullen; Andreas D Flouris; Murray Laugesen; Thomas Eissenberg Journal: Tob Control Date: 2011-03-17 Impact factor: 7.552
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: Timothy E O'Toole; Xiaohong Li; Daniel W Riggs; David J Hoetker; Ray Yeager; Pawel Lorkiewicz; Shahid P Baba; Nigel G F Cooper; Aruni Bhatnagar Journal: Inhal Toxicol Date: 2020-11-12 Impact factor: 2.724
Authors: Ray Yeager; Daniel W Riggs; Natasha DeJarnett; Shweta Srivastava; Pawel Lorkiewicz; Zhengzhi Xie; Tatiana Krivokhizhina; Rachel J Keith; Sanjay Srivastava; Matthew H E M Browning; Nagma Zafar; Sathya Krishnasamy; Andrew DeFilippis; Jay Turner; Shesh N Rai; Aruni Bhatnagar Journal: Sci Total Environ Date: 2019-11-23 Impact factor: 7.963
Authors: Katlyn E McGraw; Daniel W Riggs; Shesh Rai; Ana Navas-Acien; Zhengzhi Xie; Pawel Lorkiewicz; Jordan Lynch; Nagma Zafar; Sathya Krishnasamy; Kira C Taylor; Daniel J Conklin; Andrew P DeFilippis; Sanjay Srivastava; Aruni Bhatnagar Journal: Environ Res Date: 2021-02-24 Impact factor: 6.498
Authors: Alma Nieto; Luyu Zhang; Deepak Bhandari; Wanzhe Zhu; Benjamin C Blount; Víctor R De Jesús Journal: Biomarkers Date: 2021-04-08 Impact factor: 2.663
Authors: Wubin Xie; Hasmeena Kathuria; Panagis Galiatsatos; Michael J Blaha; Naomi M Hamburg; Rose Marie Robertson; Aruni Bhatnagar; Emelia J Benjamin; Andrew C Stokes Journal: JAMA Netw Open Date: 2020-11-02